✦ LIBER ✦

PMS41 Persistency with Subcutaneous Anti-TNF Therapy for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Patients

✍ Scribed by N. Tandon; S. Haas; H. Waters; W. Olson; S. Bolge; C. Gunnarsson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Observational study of switching anti-TN

✍ Guenther Haberhauer; Christoph Strehblow; Peter Fasching 📂 Article 📅 2010 🏛 Springer Vienna 🌐 German ⚖ 165 KB

Efficacy and safety of adalimumab treatm

✍ Poddubnyy, Denis; Rudwaleit, Martin 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 391 KB

Effects of anti-TNF therapy on glucose m

✍ Bárbara Santos Pires da Silva; Eloísa Bonfá; Júlio César Bertacini de Moraes; Ca 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 110 KB

PMS64 PATIENT EXPERIENCE WITH SUBCUTANEO

✍ N. Tandon; S. Bolge; K. Annunziata 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PMS17 Cost Minimization of Anti-TNF Biol

✍ A.D. Morais; M.L. Pereira 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PMS12 Budget Impact of Golimumab in the

✍ A.D. Morais; M.L. Pereira 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB